Brum Evelyne Silva, Landini Lorenzo, Souza Monteiro de Araújo Daniel, Marini Matilde, Geppetti Pierangelo, Nassini Romina, De Logu Francesco, Oliveira Sara Marchesan
Graduate Program in Biological Sciences: Biochemistry, Department of Biochemistry, Institute of Basic Health Sciences, Universidade Federal do Rio Grande do Sul, 90035-003, Porto Alegre, RS, Brazil; Graduate Program in Biological Sciences: Toxicological Biochemistry, Centre of Natural and Exact Sciences, Federal University of Santa Maria, Santa Maria, RS, Brazil.
Department of Health Sciences, Clinical Pharmacology Unit, University of Florence, Florence, Italy.
Free Radic Biol Med. 2025 Mar 1;229:289-299. doi: 10.1016/j.freeradbiomed.2025.01.040. Epub 2025 Jan 20.
Fibromyalgia (FM) is a complex and multifaceted condition characterized by a range of clinical symptoms, including widespread pain and a strong association with migraine headaches. Recent findings have underscored the role of oxidative stress and transient receptor potential ankyrin 1 (TRPA1) channel in migraine and FM. However, the precise mechanisms underlying the comorbidity between migraine and FM are unclear. Periorbital mechanical allodynia (PMA), which recapitulates one of the major symptoms of migraine, and the feed-forward mechanism driven by reactive oxygen species and TRPA1, were investigated in a reserpine-induced FM model in C57BL/6J mice, employing pharmacological interventions and genetic approaches. Reserpine-treated mice developed PMA (which was alleviated by antimigraine drugs) and increased endoneurial macrophages and oxidative stress markers in the trigeminal nerve tissues (neuroinflammation). These responses were absent upon macrophage depletion and by pharmacological inhibition or global genetic deletion of the TRPA1 channel. Furthermore, selective silencing of TRPA1 in Schwann cells attenuated both reserpine-induced PMA and neuroinflammation, while selective silencing of TRPA1 in sensory neurons reduced PMA but not neuroinflammation. In reserpine-treated mice, Schwann cell TRPA1 promoted NADPH oxidase 1-mediated reactive oxygen species generation and macrophage density increase in the mouse trigeminal nerve, which sustains PMA. Targeting TRPA1 channels in Schwann cells could offer a novel therapeutic strategy for FM-related headaches.
纤维肌痛(FM)是一种复杂且多方面的病症,其特征为一系列临床症状,包括广泛疼痛以及与偏头痛的紧密关联。最近的研究结果强调了氧化应激和瞬时受体电位锚蛋白1(TRPA1)通道在偏头痛和纤维肌痛中的作用。然而,偏头痛和纤维肌痛共病的精确机制尚不清楚。在C57BL/6J小鼠的利血平诱导的纤维肌痛模型中,采用药理学干预和基因方法,研究了模拟偏头痛主要症状之一的眶周机械性痛觉过敏(PMA)以及由活性氧和TRPA1驱动的前馈机制。经利血平处理的小鼠出现了PMA(抗偏头痛药物可缓解),并且三叉神经组织中的神经内膜巨噬细胞和氧化应激标志物增加(神经炎症)。巨噬细胞耗竭以及TRPA1通道的药理学抑制或整体基因缺失后,这些反应消失。此外,雪旺细胞中TRPA1的选择性沉默减弱了利血平诱导的PMA和神经炎症,而感觉神经元中TRPA1的选择性沉默减少了PMA但未减少神经炎症。在经利血平处理的小鼠中,雪旺细胞TRPA1促进了烟酰胺腺嘌呤二核苷酸磷酸氧化酶1介导的活性氧生成以及小鼠三叉神经中巨噬细胞密度的增加,从而维持了PMA。靶向雪旺细胞中的TRPA1通道可能为纤维肌痛相关头痛提供一种新的治疗策略。